GenomOncology
GenomOncology: Transforming data into actionable insights for improved cancer care.
Founded
2012GenomOncology: Transforming data into actionable insights for improved cancer care.
Founded with a mission to revolutionize cancer care, GenomOncology is a data-driven healthcare technology company that transforms complex oncology data into actionable insights. The company's core vision is to enhance precision oncology programs by making valuable but previously unusable data accessible and actionable. GenomOncology offers a range of solutions, including a Precision Oncology Platform, Data Enablement, Pathology Decision Support, and Insights & Analytics. These services aim to provide strategic insights and treatment options that drive measurable improvements in cancer care.
GenomOncology has garnered attention for its innovative approach and impact on the healthcare community. The company is supported by a team of experts and thought leaders in oncology and healthcare technology. Notable achievements include the successful implementation of their solutions in various healthcare institutions, leading to improved patient outcomes and more efficient cancer treatment protocols. By setting new standards in cancer care, GenomOncology continues to make significant strides in the fight against cancer.
Companies similar to GenomOncology include Onc.AI, xCures, MyCancerDB and D2G Oncology.
GenomOncology was founded in 2012.
GenomOncology's headquarters is located in Cleveland, OH, US.
GenomOncology's most recent funding round was for $1.4M (USD) in November 2019.
As of Nov 22, 2019, GenomOncology has disclosed funding of $2.9M (USD). Undisclosed round amounts are excluded.
GenomOncology has 62 employees as of Feb 5, 2024.
D2G Oncology
d2g-oncology.com
